sobuzoxane has been researched along with at 2153 in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (50.00) | 29.6817 |
| 2010's | 2 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ding, J; Hu, CX; Huang, M; Li, MH; Lin, LP; Lu, DY; Lu, W; Tong, LJ; Xu, CH; Yang, WY; Zhang, XW | 1 |
| Ding, J; Huang, M; Lu, DY; Xu, B; Xu, CH; Zhu, H | 1 |
| Lu, DY; Lu, TR | 2 |
2 review(s) available for sobuzoxane and at 2153
| Article | Year |
|---|---|
Anticancer activities and mechanisms of bisdioxopiperazine compounds probimane and MST-16.
Topics: Animals; Antineoplastic Agents; Cell Cycle; Cell Line, Tumor; Humans; Mice; Mice, Inbred C57BL; Piperazines; Razoxane | 2010 |
Antimetastatic activities and mechanisms of bisdioxopiperazine compounds.
Topics: Angiogenesis Inhibitors; Animals; Antineoplastic Agents; Cell Line, Transformed; Fibrinogen; Humans; Mice; Molecular Targeted Therapy; Neoplasm Metastasis; Piperazines; Razoxane | 2010 |
2 other study(ies) available for sobuzoxane and at 2153
| Article | Year |
|---|---|
Anti-proliferative effects, cell cycle G2/M phase arrest and blocking of chromosome segregation by probimane and MST-16 in human tumor cell lines.
Topics: Antineoplastic Agents; Chromosome Segregation; G2 Phase; Humans; Piperazines; Razoxane; Tumor Cells, Cultured | 2005 |
Medicinal chemistry of probimane and MST-16: comparison of anticancer effects between bisdioxopiperazines.
Topics: Animals; Antineoplastic Agents; Carcinoma, Lewis Lung; Cell Line, Tumor; Cell Proliferation; Cell Survival; Dose-Response Relationship, Drug; Drug Administration Schedule; Humans; Mice; Mice, Nude; Molecular Structure; Piperazines; Razoxane; Structure-Activity Relationship; Time Factors; Xenograft Model Antitumor Assays | 2006 |